# Derralynn Hughes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/derralynn-hughes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,737 |
| Field | Lysosomal Storage Disorders Research |
| h-index | 75 |
| i10-index | 238 |
| Last Known Institution | Royal Free London NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5016812185 |
| ORCID iD | https://orcid.org/0000-0003-4531-9173 |
| Works | 700 |

## Researcher papers

- [Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat](https://scholariq.org/papers/treatment-of-fabry-s-disease-with-the-pharmacologic-chaperone-migalastat/)
- [Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study](https://scholariq.org/papers/oral-pharmacological-chaperone-migalastat-compared-with-enzyme-replacement/)
- [Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document](https://scholariq.org/papers/recommendations-for-initiation-and-cessation-of-enzyme-replacement-therapy-in/)
- [An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease](https://scholariq.org/papers/an-expert-consensus-document-on-the-management-of-cardiovascular-manifestations/)
- [Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study](https://scholariq.org/papers/efficacy-and-safety-of-enzyme-replacement-therapy-with-bmn-110-elosulfase-alfa/)
- [Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial](https://scholariq.org/papers/safety-and-efficacy-of-avalglucosidase-alfa-versus-alglucosidase-alfa-in/)
- [Proposed Stages of Myocardial Phenotype Development in Fabry Disease](https://scholariq.org/papers/proposed-stages-of-myocardial-phenotype-development-in-fabry-disease/)

## Researcher topics

- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)
- [Glycogen Storage Diseases and Myoclonus](https://scholariq.org/topics/glycogen-storage-diseases-and-myoclonus/)
- [Trypanosoma species research and implications](https://scholariq.org/topics/trypanosoma-species-research-and-implications-2/)
- [Carbohydrate Chemistry and Synthesis](https://scholariq.org/topics/carbohydrate-chemistry-and-synthesis/)
- [Cellular transport and secretion](https://scholariq.org/topics/cellular-transport-and-secretion/)

## Researcher university

- [Royal Free London NHS Foundation Trust](https://scholariq.org/institutions/royal-free-london-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.